Burstein Jennifer

CIK 00016400692 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001640069

Recent Transactions

50 trades

Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2026-06-03+17,786→ 17,786 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2023-06-13+19,441→ 19,441 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2022-06-07+21,000→ 21,000 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2021-06-08+11,650→ 11,650 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2020-06-03+14,777→ 14,777 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2019-09-10+29,555→ 29,555 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−12,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−20,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−28,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−17,500→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−28,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−40,000→ 0 total
Award
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-01-02+20,000→ 20,000 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-12-11−1,250→ 17,500 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$139.36/sh−100→ 100 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$140.48/sh−100→ 0 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$135.69/sh−200→ 1,050 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$137.88/sh−263→ 200 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-12-11$11.35/sh+1,250→ 1,250 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-11$136.98/sh−587→ 463 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$130.79/sh−100→ 1,150 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$132.44/sh−400→ 750 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$133.34/sh−100→ 650 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-12-10−1,250→ 18,750 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$134.71/sh−550→ 100 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-12-10$136.04/sh−100→ 0 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-12-10$11.35/sh+1,250→ 1,250 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$137.89/sh−200→ 1,050 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-11-27−1,250→ 20,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$151.55/sh−100→ 0 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$148.20/sh−100→ 100 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-11-27$11.35/sh+1,250→ 1,250 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$147.09/sh−100→ 200 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$140.94/sh−200→ 500 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$143.84/sh−200→ 300 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-27$138.95/sh−350→ 700 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-26$156.04/sh−100→ 0 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-26$151.57/sh−500→ 750 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-11-26−1,250→ 21,250 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-26$155.13/sh−300→ 100 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-26$153.30/sh−100→ 400 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-11-26$152.39/sh−250→ 500 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-11-26$11.35/sh+1,250→ 1,250 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-04$162.54/sh−311→ 400 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-04$164.25/sh−200→ 200 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-04$165.05/sh−200→ 0 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-10-04$161.22/sh−539→ 711 total
Exercise/Conversion
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2018-10-04−1,250→ 22,500 total

Companies

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov